Intentar ORO - Gratis
NEW TECHNOLOGIES FOR ORGAN PRESERVATION IN INDIA: SAVING LIVES AND MOVING SCIENCE FORWARD
Healthcare Radius
|August 2025
Organ preservation is no longer just a technique to buy time. It's about adding value to each precious organ, making sure it operates as effectively as possible, and achieving the best results for the people who get it.
One of the most remarkable things that modern medicine has done is transplant organs. It gives those who are about to die from organ failure a second chance at life. Transplant technology has come a long way over the years, but the success of every transplant still rests on one very crucial thing: the preservation of the given organ.
In India, where people are progressively becoming more conscious of organ donation and the infrastructure for transplant programs is getting stronger, they are now focused on a less well-known but extremely critical aspect of transplant success: organ preservation technology.
The Early Era: Cold Storage and its Limits
For years, static cold storage (SCS) has been the best approach to keep organs alive in India and around the world. After being pulled out, organs are cleaned using a preservation solution like University of Wisconsin (UW), Custodiol HTK, or Euro-Collins and maintained in ice-cold temperatures (typically 0–4°C) to slow down how quickly cells break down.
Cold storage is cheap, simple, and accepted by everyone. It still works so effectively that most Indian hospitals use it for kidney transplants. Usually, cold storage is enough to keep the organs alive if they are just being moved for 6 to 8 hours.
But its limits become clear in the following cases:
• Moving things over long distances, such between states or across the country,
• Ischaemia that lasts longer,
• Using "marginal organs" from older donors or donors with significant health concerns,
• Deceased donor transplants, if the time to preserve organ is already extended,
• A difference between supply and demand that makes it take longer to move organs.
India requires more modern, adaptable preservation technologies to keep up with the growing number of transplants, the larger area they serve, and the higher reliance on programs that use deceased donors.
Esta historia es de la edición August 2025 de Healthcare Radius.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Healthcare Radius
Healthcare Radius
VENUS REMEDIES GETS DRUG APPROVALS IN VIETNAM
Venus Remedies, a fixed-dosage injectable manufacturer, has secured new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam.
1 mins
December 2025
Healthcare Radius
A HEALTHIER INDIA IN THE MAKING: LEADERS DECODE THE ROAD FROM 2025 TO 2026
The collective goal is clear and unanimous: to transition from a system that primarily treats sickness to one that actively promotes lifelong health and well-being.
12 mins
December 2025
Healthcare Radius
FROM GENES TO CARE: ADVANCING CLINICAL UNDERSTANDING OF HYPOPHOSPHATASIA
From genes to care, the story of hypophosphatasia reminds us that progress in medicine isn't only about scientific discovery, it's about turning knowledge into healing.
6 mins
December 2025
Healthcare Radius
ALEMBIC PHARMA GETS USFDA NOD FOR DILTIAZEM TABLETS IN THE US
Alembic Pharmaceuticals (Alembic) Aamour announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.
1 min
December 2025
Healthcare Radius
ZYDUS GETS USFDA APPROVAL FOR PROSTATE CANCER INJECTABLE
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: Lupron Injection®, 1 mg/0.2 mL).
1 min
December 2025
Healthcare Radius
SUPERHEALTH LAUNCHES HONEST SECOND OPINION FOR PATIENTS
Superhealth, a zero-wait, commission Superhealth, zerohospital network, announced the launch of \"Honest Second Opinion,\" a service that helps patients make informed decisions about their treatment plans and surgical recommendations.
1 min
December 2025
Healthcare Radius
KOTAK ALTS INVESTS RS 400MN IN MEDIVERSAL
Kotak Alternate Asset Managers (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 400 million in Mediversal Healthcare.
1 min
December 2025
Healthcare Radius
INVIGA HEALTHCARE FUND ACQUIRES 21% STAKE IN FORUS HEALTH
Inviga Healthcare Fund (IHF), the private equity platform founded by Dr B. S. Ajaikumar of HCG, has acquired a 21 per cent stake in Forus Health, an ophthalmic diagnostics company whose devices have screened over 22 million patients across 75+ countries.
1 min
December 2025
Healthcare Radius
OPTIMISING MATERNITY OPS: REDUCING C-SECTION BURDEN THROUGH EVIDENCE-BASED PROTOCOLS
By building systems that support safety, documentation, and respectful care, institutions can improve outcomes, lower litigation risks, and strengthen quality scores, achieving what healthcare should truly represent: Care Through Trust.”
7 mins
December 2025
Healthcare Radius
MENTAL HEALTH CARE GOES DIGITAL WITH NEW THERAPY PLATFORM
Following the global observance and continuing the commitment to mental well-being, renowned clinical psychologist Kanika Jindal announced the launch of Harmony Therapy World, a holistic digital platform designed to bring emotional healing and psychological support to people everywhere, privately, compassionately, and without barriers.
1 min
December 2025
Listen
Translate
Change font size
